TORONTO, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory ...
Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for ...
The global Microcarriers market, valued at US$2.03 billion in 2023, is forecasted to grow at a robust CAGR of 8.0%, reaching US$2.08 billion ...
Financing led by Velan Capital with participation from new and existing healthcare-focused institutional investors and insidersCapital raise to ...
Supported by the Government of Canada's Youth Employment and Skills Strategy Program, Career Starter equips young Canadians with opportunities to secure sustainable employment. This program addresses ...
The Duchess of Sussex returned to California solo after kicking off the Invictus Games in Canada with Prince Harry ...
Universal Kraft Canada Renewables, a joint venture between Korkia and Universal Kraft, announced a USD 15 million initial ...
Syantra, Inc., a precision biotechnology company revolutionizing cancer detection and treatment, proudly announces Dr. Edith A. Perez as chair and Dr. Maria Theodoulou and Dr. Adetunji Toriola as ...
Merck KGaA, the German healthcare and technology group, is in advanced talks to acquire U.S. cancer and rare diseases drugmaker Springworks Therapeutics, according to people familiar with the matter.
Innocan Pharma Corporation ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries, is pleased to announce the successful outcome from the compassionate treatment of ...
5don MSN
Merck KGaA, the German healthcare and technology group, is in advanced talks to acquire U.S. cancer and rare diseases ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback